Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Seminars in Oncology
|
December 10, 1999
Single-agent vinorelbine in the treatment of non-small cell lung cancer
A J Wozniak
Cancer Research
|
January 1, 1983
DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity
A J Wozniak, W E Ross
Critical Reviews in Oncology/Hematology
|
February 1, 1993
Neurotoxicity of antineoplastic agents
M Hussain, A J Wozniak, M B Edelstein
The Annals of Pharmacotherapy
|
February 24, 2001
Anticoagulation therapy for radiation-induced myelopathy
C Y Liu, B T Yim, A J Wozniak
Cancer Research
|
February 1, 1984
Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents
A J Wozniak, B S Glisson, K R Hande, et al.
Cancer Investigation
|
March 4, 2000
A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer
M A Ali, M J Kraut, M Valdivieso, et al.
Cancer Investigation
|
May 8, 2001
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer
G P Kalemkerian, M A Ali, K Luthra, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer
G P Kalemkerian, K Belzer, A J Wozniak, et al.
Cancer
|
June 15, 1993
Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study
A J Wozniak, B A Blumenstein, E D Crawford, et al.
Chest
|
May 20, 1999
Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program
S M Gadgeel, S Ramalingam, G Cummings, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Seminars in Oncology
|
December 10, 1999
Single-agent vinorelbine in the treatment of non-small cell lung cancer
A J Wozniak
Cancer Research
|
January 1, 1983
DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity
A J Wozniak, W E Ross
Critical Reviews in Oncology/Hematology
|
February 1, 1993
Neurotoxicity of antineoplastic agents
M Hussain, A J Wozniak, M B Edelstein
The Annals of Pharmacotherapy
|
February 24, 2001
Anticoagulation therapy for radiation-induced myelopathy
C Y Liu, B T Yim, A J Wozniak
Cancer Research
|
February 1, 1984
Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents
A J Wozniak, B S Glisson, K R Hande, et al.
Cancer Investigation
|
March 4, 2000
A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer
M A Ali, M J Kraut, M Valdivieso, et al.
Cancer Investigation
|
May 8, 2001
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer
G P Kalemkerian, M A Ali, K Luthra, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer
G P Kalemkerian, K Belzer, A J Wozniak, et al.
Cancer
|
June 15, 1993
Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study
A J Wozniak, B A Blumenstein, E D Crawford, et al.
Chest
|
May 20, 1999
Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program
S M Gadgeel, S Ramalingam, G Cummings, et al.
Page
of 2